Shire to acquire specialty drugmaker NPS Pharmaceuticals for $5.2 Billion

Shire to acquire specialty drugmaker NPS Pharmaceuticals for $5.2 Billion

By Carrie Ann - Jan 13, 2015

Shire now wants to pursue its goal to become a biotech powerhouse through acquisitions. Irish drugmaker Shire PLC announced Sunday it has agreed to pay $5.2bn (£3.4bn, €4.4bn) i

Read More
Astrazeneca Transitions to 'For-Profit Model' for Covid-19 Vaccine

Astrazeneca Transitions to 'For-Profit Model' for Covid-19 Vaccine

By Anna Domanska - Nov 14, 2021

AstraZeneca, the Anglo Swedish pharma company, which developed the Covid-19 vaccine with the University of Oxford, is moving away from its non-profit model and for it. The drugmake

Read More
Best Pharma Stocks to Buy Right Now

Best Pharma Stocks to Buy Right Now

By Christy Gren - Oct 22, 2021

Industry Leaders has curated a brief list of the best pharmaceutical stocks you can buy right now, along with a list of pharma penny stocks that have the best potential to grow in

Read More
Bain Capital gives up majority stake in South Korea Botox Company for $1.5 billion

Bain Capital gives up majority stake in South Korea Botox Company for $1.5 billion

By Christy Gren - Aug 26, 2021

South Korea’s biggest producer of botulinum toxin, Hugel is concerned about its expansion now as Botox Company is sold.

Read More
Dividend Payments see global recovery to the tune of $471.7 billion

Dividend Payments see global recovery to the tune of $471.7 billion

By Christy Gren - Aug 24, 2021

Global dividends can see pay-outs reach the good old pre-pandemic levels with economic balance in some major countries.

Read More
Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

Bayer snaps up biotech firm Vividion Therapeutics for $2 billion

By Christy Gren - Aug 05, 2021

Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.

Read More
Alden Global offers $520 million for Tribune Publishing

Alden Global offers $520 million for Tribune Publishing

By Christy Gren - Jan 04, 2021

Alden Global Capital, a US hedge fund, plans to acquire Tribune Publishing valuing the publishing company at $520m.

Read More
Top Biopharma Leaders of the Year

Top Biopharma Leaders of the Year

By Christy Gren - Dec 28, 2020

The Covid-19 pandemic of 2020 has thrust the pharmaceutical and biotech industry centerstage with almost all the major players in the industry engaged in coming up with a solution

Read More
Eli Lilly’s antibody treatment gets emergency-use clearance by FDA

Eli Lilly’s antibody treatment gets emergency-use clearance by FDA

By Christy Gren - Nov 10, 2020

Be the first to know about the latest COVID vaccine updates along with developments on Pfizer vaccine here at your favorite CEO magazine, Industry Leaders.

Read More